Yanjiao Xu

691 total citations
35 papers, 481 citations indexed

About

Yanjiao Xu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yanjiao Xu has authored 35 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Yanjiao Xu's work include Drug Transport and Resistance Mechanisms (8 papers), Computational Drug Discovery Methods (6 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Yanjiao Xu is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Computational Drug Discovery Methods (6 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Yanjiao Xu collaborates with scholars based in China, United States and Netherlands. Yanjiao Xu's co-authors include Chengliang Zhang, Dong Liu, Dong Liu, Xiping Li, Tao Wu, Wenxi He, Dong Xiang, Jinyu Yang, Kai Lei and Xiuhua Ren and has published in prestigious journals such as PLoS ONE, Nutrients and Journal of Ethnopharmacology.

In The Last Decade

Yanjiao Xu

33 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanjiao Xu China 15 147 114 105 100 91 35 481
Mohammad K. Miah United States 8 175 1.2× 174 1.5× 128 1.2× 44 0.4× 71 0.8× 13 573
Yinxiao Jiang China 12 161 1.1× 122 1.1× 63 0.6× 52 0.5× 139 1.5× 17 489
Omar Abdulhameed Almazroo United States 4 153 1.0× 174 1.5× 87 0.8× 42 0.4× 56 0.6× 6 505
Chenshu Xu China 17 271 1.8× 347 3.0× 226 2.2× 74 0.7× 78 0.9× 31 834
Furong Qiu China 13 164 1.1× 211 1.9× 92 0.9× 120 1.2× 45 0.5× 27 457
Michael Atef Fawzy Egypt 14 197 1.3× 106 0.9× 63 0.6× 60 0.6× 80 0.9× 42 566
Fan Cheung Hong Kong 7 286 1.9× 251 2.2× 49 0.5× 110 1.1× 101 1.1× 8 663
Xue‐Rong Xiao China 17 260 1.8× 180 1.6× 125 1.2× 47 0.5× 77 0.8× 33 603
Zeyu Zhong China 16 255 1.7× 145 1.3× 163 1.6× 51 0.5× 57 0.6× 40 552
Shuang Xia China 13 205 1.4× 74 0.6× 62 0.6× 71 0.7× 47 0.5× 28 557

Countries citing papers authored by Yanjiao Xu

Since Specialization
Citations

This map shows the geographic impact of Yanjiao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjiao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjiao Xu more than expected).

Fields of papers citing papers by Yanjiao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjiao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjiao Xu. The network helps show where Yanjiao Xu may publish in the future.

Co-authorship network of co-authors of Yanjiao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjiao Xu. A scholar is included among the top collaborators of Yanjiao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjiao Xu. Yanjiao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yongsheng, et al.. (2025). The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression. Frontiers in Pharmacology. 16. 1559408–1559408. 1 indexed citations
2.
Yang, Runjun, Xiu Zhao, Guisheng Xiang, et al.. (2025). Identification and catalytic mechanisms of key enzymes in the biosynthesis of asperosaponin VI from Dipsacus asperoides. Plant Physiology and Biochemistry. 227. 110166–110166.
3.
Gao, Ping, Min Li, Ximin Wang, et al.. (2023). IL-33 Downregulates Hepatic Carboxylesterase 1 in Acute Liver Injury via Macrophage-Derived Exosomal miR-27b-3p. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 6 indexed citations
4.
Xu, Yanjiao, Yuxin Wang, & Chanjuan Liu. (2022). Training a Reinforcement Learning Agent with AutoRL for Traffic Signal Control. 51–55. 3 indexed citations
5.
Li, Guodong, Yanjiao Xu, Sheng Guo, et al.. (2022). Ginsenosides Restore Lipid and Redox Homeostasis in Mice with Intrahepatic Cholestasis through SIRT1/AMPK Pathways. Nutrients. 14(19). 3938–3938. 13 indexed citations
6.
Li, Min, Si Zhang, Yanjiao Xu, et al.. (2021). IL-6 downregulates hepatic carboxylesterases via NF-κB activation in dextran sulfate sodium-induced colitis. International Immunopharmacology. 99. 107920–107920. 11 indexed citations
7.
Yang, Jinyu, Yanjiao Xu, Si Zhang, et al.. (2020). Protective effect of Andrographolide on 5-Fu induced intestinal mucositis by regulating p38 MAPK signaling pathway. Life Sciences. 252. 117612–117612. 39 indexed citations
8.
He, Wenxi, Yanjiao Xu, Xiuhua Ren, et al.. (2019). Vitamin E Ameliorates Lipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease via Nrf2/CES1 Signaling Pathway. Digestive Diseases and Sciences. 64(11). 3182–3191. 38 indexed citations
9.
Zhang, Chengliang, Yanjiao Xu, Dong Xiang, et al.. (2018). Pharmacokinetic Characteristics of Baicalin in Rats with 17α-ethynyl-estradiol-induced Intrahepatic Cholestasis. Current Medical Science. 38(1). 167–173. 20 indexed citations
10.
He, Wenxi, Yanjiao Xu, Chengliang Zhang, et al.. (2017). Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes. Drug Design Development and Therapy. Volume 11. 3449–3460. 15 indexed citations
11.
Xiang, Dong, Tao Wu, Xiping Li, et al.. (2017). Upregulation of PDZK1 by Calculus Bovis Sativus May Play an Important Role in Restoring Biliary Transport Function in Intrahepatic Cholestasis. Evidence-based Complementary and Alternative Medicine. 2017(1). 1640187–1640187. 8 indexed citations
12.
Li, Xiping, et al.. (2015). Protective Effect ofCalculus Bovis Sativuson Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice. Evidence-based Complementary and Alternative Medicine. 2015. 1–8. 25 indexed citations
13.
Zhang, Chengliang, Yanjiao Xu, Ping Gao, et al.. (2014). Down-regulation of carboxylesterases 1 and 2 plays an important role in prodrug metabolism in immunological liver injury rats. International Immunopharmacology. 24(2). 153–158. 16 indexed citations
14.
Zhang, Chengliang, et al.. (2014). Chronopharmacodynamics and Chronopharmacokinetics of Pethidine in Mice. PLoS ONE. 9(7). e102054–e102054. 16 indexed citations
15.
Li, Xiping, Ping Gao, Chengliang Zhang, et al.. (2014). Reduced bioavailability of cyclosporine A in rats by mung bean seed coat extract. Brazilian Journal of Pharmaceutical Sciences. 50(3). 591–597.
16.
Zhang, Chengliang, Xiping Li, Yanjiao Xu, et al.. (2013). Simultaneous Determination of Pethidine and Norpethidine in Mouse Plasma by Liquid Chromatography–Electrospray Ionization Source-Mass Spectrometry. Journal of Analytical Toxicology. 37(6). 351–356. 5 indexed citations
17.
Wu, Tao, et al.. (2013). Protective Effect of Calculus Bovis Sativus on Intrahepatic Cholestasis in Rats Induced by α-Naphthylisothiocyanate. The American Journal of Chinese Medicine. 41(6). 1393–1405. 21 indexed citations
18.
Xu, Yanjiao, et al.. (2013). Evaluation of the Inhibitory Effects of Antihypertensive Drugs on Human Carboxylesterase In Vitro. Drug Metabolism and Pharmacokinetics. 28(6). 468–474. 25 indexed citations
19.
20.
Liu, Dong, et al.. (2011). Preparation of anti-HER2 monoclonal antibody-paclitaxel immunoconjugate and its biological evaluation. Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(6). 735–740. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad K. Miah Breakdown of academic impact, for papers by Yinxiao Jiang Breakdown of academic impact, for papers by Omar Abdulhameed Almazroo Breakdown of academic impact, for papers by Chenshu Xu Breakdown of academic impact, for papers by Furong Qiu Breakdown of academic impact, for papers by Michael Atef Fawzy Breakdown of academic impact, for papers by Fan Cheung Breakdown of academic impact, for papers by Xue‐Rong Xiao Breakdown of academic impact, for papers by Zeyu Zhong Breakdown of academic impact, for papers by Shuang Xia
Rankless by CCL
2026